A nasal spray can seem simpler than an injection, especially if needles are a barrier to treatment. Sermorelin nasal products also raise their own questions: how much medicine is absorbed, whether each spray delivers a consistent amount, and what outcomes have been studied in people like you.
There is human research on intranasal growth-hormone-releasing hormone, including older work involving GHRH(1-29). The results are more nuanced than either “nasal peptides never work” or “a spray works just like an injection.” The specific molecule, formulation, and population matter.
Nasal delivery has been studied, but findings depend on the molecule and formulation. Modern sermorelin spray benefits cannot be assumed from injection studies.
What the pharmacokinetic research found
A 1993 study of GHRH(1-29)-NH2 compared intravenous and intranasal administration in healthy participants. It reported low nasal bioavailability, approximately 3–5%, in the studied preparation, with a dose-dependent growth hormone response.
That percentage belongs to that experiment. It is not a verified absorption percentage for every current compounded spray, and it is not a conversion factor for changing your prescription. The study measured hormone-related responses rather than proving a modern spray improves long-term sleep, strength, or healthy aging.
An important pediatric study had limitations
A 1993 six-month pilot in eight children examined intranasal GHRH(1-29). Responses declined over time, local irritation occurred, and the measured six-month height velocity did not increase. The authors did not consider that formulation suitable for the intended pediatric use.
This is relevant evidence against blanket reassurance about nasal delivery. It is also a small study in children with a particular formulation, not a modern trial in adults over 50. It should not be used to claim that every later nasal product is identical or to make a treatment decision for a child without specialist care.
Some nasal studies used a different molecule
A 1990 placebo-controlled study in young men used GHRH(1-44), not sermorelin's GHRH(1-29) sequence. It reported growth hormone responses after nasal administration. Citing it simply as a trial of today's sermorelin spray would erase an important difference.
When a provider refers to “clinical studies,” ask for the exact citation and formulation. Our route comparison explains why research on one delivery method cannot automatically establish another product's effects.
What to ask about a current prescription
Ask for the active ingredients, concentration, amount delivered by the supplied pump, priming instructions, and storage requirements. Confirm what to do if a spray misfires or seems to run out of the nose. Do not repeat it based on appearance without product-specific advice.
Tell the prescriber about nasal irritation, congestion, recent nasal procedures, and other sprays. The care team should explain whether those circumstances affect use. A product with no needle can still require careful administration and monitoring.
Comparing spray providers
Our AgelessRx review notes its separate nasal offering alongside its injection program. Confirm the current product and price directly, because a price for injections does not establish the spray's terms or availability in your state.
Ask providers whether they have human data on the actual formulation and which outcomes that data supports. The FDA's compounding explanation makes clear that compounding is not the same as product approval. An appealing format should not be sold as clinically equivalent without evidence.
Decide whether the tradeoff fits your goal
If avoiding injections is your main concern, discuss the uncertainty of the alternative route as well as its convenience. Our tablet and troche guide covers another needle-free option, with different administration and evidence questions.
Agree on a follow-up point and what would count as a useful result. Persistent nasal symptoms, unclear dosing directions, or an absence of meaningful benefit are reasons to contact the treating team. A convenient routine is valuable only if the overall treatment decision remains sensible for you.
Sources & further reading
Provider pages describe offers; they do not independently establish treatment benefits. Sources checked September 20, 2026.
This article is education, not a diagnosis, prescription, or dosing plan. Discuss treatment and alternatives with a licensed clinician who knows your history. Compounded medications are not FDA-approved.